Clinical Professor and Medical Director
Department of Dermatology
Mount Sinai Beth Israel Hospital
New York, NY
Grant/Research Support: AnaptysBio, Janssen, Novartis, Ortho Dermatologics, Sun Pharma, BMS, and UCB Pharma; all funds go to the Icahn School of Medicine at Mount Sinai
Speakers’ Bureau or Honoraria: Amgen, AnaptysBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dice Therapeutics, Dermavant, Eli Lilly, Janssen, Novartis, Pfizer, Sanofi, Sun Pharma, UCB Pharma, and Xbiotech (stock options for an RA project);
Other Financial Benefit: XBIOTECH stock options for a Rheumatoid Arthritis Project.